Gadoteridol Patent Expiration
Gadoteridol is Used for enhancing visibility of tissues and organs during magnetic resonance imaging. It was first introduced by Bracco Diagnostics Inc
Gadoteridol Patents
Given below is the list of patents protecting Gadoteridol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Prohance | US5846519 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
Dec 08, 2015
(Expired) | Bracco |
| Prohance Multipack | US5846519 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
Dec 08, 2015
(Expired) | Bracco |
| Prohance | US5474756 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
Dec 12, 2012
(Expired) | Bracco |
| Prohance | US6143274 | Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
Dec 12, 2012
(Expired) | Bracco |
| Prohance Multipack | US5474756 | Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
Dec 12, 2012
(Expired) | Bracco |
| Prohance Multipack | US6143274 | Method for imaging and radiopharmaceutical therapy using 1-substituted-4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
Dec 12, 2012
(Expired) | Bracco |
Gadoteridol's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List